Crash in biotechnology stocks; FDA hits him with clinical wait after mice develop tumors
[ad_1] Biotechnology actions Therapeutic protagonist (PTGX) crashed Friday after the Food and Drug Administration put its key drug on hold due to safety concerns. X The protagonist studies the drug, rusfertide, in patients with diseases of the blood. But the mice that received the drug developed tumors under their skin. Now the FDA says the … Read more